GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half‐life in a murine model of sickle cell disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|175|1|141-153

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.175, Iss.1, 2016-10, pp. : 141-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Voxelotor (GBT440), a first‐in‐class hemoglobin oxygen‐affinity modulator, has promising and reassuring preclinical and clinical data

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 3, 2018-03 ,pp. : 326-329

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fetal haemoglobin induction in sickle cell disease

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 2, 2018-01 ,pp. : 189-200

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 12, 2015-12 ,pp. : 1135-1141

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hydroxyurea Increases Plasma Concentrations of Microparticles and Reduces Coagulation Activation and Fibrinolysis in Patients with Sickle Cell Anemia

By  

Acta Haematologica, Vol. 133, Iss. 3, 2014-12 ,pp. : 287-294

Karger

Access to resources Recommend Favorite

Comprehensive management reduces incidence and mortality of acute chest syndrome in patients with sickle cell disease

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 3, 2018-03 ,pp. : E64-E67

John Wiley & Sons Inc

Access to resources Recommend Favorite